Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark M Awad

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
JCO Precision Oncology|February 22, 2023
Incidence of Brain Metastases and Preliminary Evidence of Intracranial Activity With Sotorasib in Patients With <i>KRAS</i><sup></sup>-Mutant Non-Small-Cell Lung CancerGiuseppe Lamberti, Ayal Aizer, Biagio Ricciuti, et al.
Cancer Research|March 3, 2021
Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung CancerXinan Wang, Biagio Ricciuti, Tom Nguyen, et al.
JTO Clinical and Research Reports|September 30, 2021
Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With <i>MET</i> Exon 14-Mutant NSCLCPaola Cravero, Nuno Vaz, Biagio Ricciuti, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2020
Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinomaSimon Baldacci, Valérie Grégoire, Enrico Patrucco, et al.
Journal for Immunotherapy of Cancer|March 30, 2019
Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancerBiagio Ricciuti, Sasha Kravets, Suzanne E Dahlberg, et al.
JCO Precision Oncology|July 12, 2021
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor ContentCatherine B Meador, Marina S D Milan, Emmy Y Hu, et al.
Frontiers in Oncology|September 23, 2021
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical CourseMizuki Nishino, Nikhil H Ramaiya, Mark M Awad, et al.
Frontiers in Oncology|June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
European Radiology|April 26, 2023
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survivalMizuki Nishino, Xinan Wang, Biagio Ricciuti, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
JCO Precision Oncology|February 22, 2023
Incidence of Brain Metastases and Preliminary Evidence of Intracranial Activity With Sotorasib in Patients With <i>KRAS</i><sup></sup>-Mutant Non-Small-Cell Lung CancerGiuseppe Lamberti, Ayal Aizer, Biagio Ricciuti, et al.
Cancer Research|March 3, 2021
Association between Smoking History and Tumor Mutation Burden in Advanced Non-Small Cell Lung CancerXinan Wang, Biagio Ricciuti, Tom Nguyen, et al.
JTO Clinical and Research Reports|September 30, 2021
Leptomeningeal Response to Capmatinib After Progression on Crizotinib in a Patient With <i>MET</i> Exon 14-Mutant NSCLCPaola Cravero, Nuno Vaz, Biagio Ricciuti, et al.
Lung Cancer (Amsterdam, Netherlands)|June 20, 2020
Complete and prolonged response to anti-PD1 therapy in an ALK rearranged lung adenocarcinomaSimon Baldacci, Valérie Grégoire, Enrico Patrucco, et al.
Journal for Immunotherapy of Cancer|March 30, 2019
Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancerBiagio Ricciuti, Sasha Kravets, Suzanne E Dahlberg, et al.
JCO Precision Oncology|July 12, 2021
High Sensitivity of Plasma Cell-Free DNA Genotyping in Cases With Evidence of Adequate Tumor ContentCatherine B Meador, Marina S D Milan, Emmy Y Hu, et al.
Frontiers in Oncology|September 23, 2021
Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2016
PD-1 Inhibitor-Related Pneumonitis in Advanced Cancer Patients: Radiographic Patterns and Clinical CourseMizuki Nishino, Nikhil H Ramaiya, Mark M Awad, et al.
Frontiers in Oncology|June 24, 2022
Corrigendum: Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib StudyMark M Awad, Yvan Le Bruchec, Brian Lu, et al.
European Radiology|April 26, 2023
Advanced non-small-cell lung cancer treated with first-line pembrolizumab plus chemotherapy: tumor response dynamics as a marker for survivalMizuki Nishino, Xinan Wang, Biagio Ricciuti, et al.
Pageof 21